WHO HPV LabNet Global Reference Laboratory, Department of Clinical and Medical Microbiology, Skåne and Lund University, Malmö, Sweden.
Vaccine. 2012 Jan 5;30(2):294-9. doi: 10.1016/j.vaccine.2011.10.096. Epub 2011 Nov 8.
We performed an international proficiency study of Human Papillomavirus (HPV) type 16 serology. A common methodology for serology based on virus-like particle (VLP) ELISA was used by 10 laboratories in 6 continents. The laboratories used the same VLP reference reagent, which was selected as the most stable, sensitive and specific VLP preparation out of VLPs donated from 5 different sources. A blinded proficiency panel consisting of 52 serum samples from women with PCR-verified HPV 16-infection, 11 control serum samples from virginal women and the WHO HPV 16 International Standard (IS) serum were distributed. The mean plus 3 standard deviations of the negative control serum samples was the most generally useful "cut-off" criterion for distinguishing positive and negative samples. Using sensitivity of at least 50% and a specificity of 100% as proficiency criteria, 6/10 laboratories were proficient. In conclusion, an international Standard Operating Procedure for HPV serology, an international reporting system in International Units (IU) and a common "cut-off" criterion have been evaluated in an international HPV serology proficiency study.
我们进行了一项关于人乳头瘤病毒(HPV)16 型血清学的国际能力验证研究。10 个实验室分布在 6 个大洲,采用了基于病毒样颗粒(VLP)ELISA 的常见血清学方法。这些实验室使用了相同的 VLP 参考试剂,该试剂是从 5 个不同来源捐赠的 VLPs 中选择出来的最稳定、最敏感和最特异的 VLP 制剂。一个由 52 份经 PCR 证实 HPV 16 感染的妇女血清样本、11 份来自处女的对照血清样本和世界卫生组织 HPV 16 国际标准(IS)血清组成的盲法能力验证小组被分发出去。阴性对照血清样本的平均值加上 3 个标准差是最普遍有用的“截断”标准,用于区分阳性和阴性样本。使用至少 50%的敏感性和 100%的特异性作为能力验证标准,有 6/10 的实验室具有能力。总之,在一项国际 HPV 血清学能力验证研究中,评估了一种国际 HPV 血清学标准操作程序、国际单位(IU)报告系统和共同的“截断”标准。